Biotech Firms Report Advances in Hepatitis C Drugs | 10-Jan-2006 | Washington Post |
Currency | US Dollars |
Share Price | $ 0.00 |
Closing Price Change | $ 0.00 |
% Change | 0.00 % |
52 Week High | $0.00 |
52 Week Low | $0.00 |
Volume | 0 |
Shares Issued | 151.50m |
You are here: research